Our Services
Medical Information
Helpful Resources
Published on: 4/24/2026
Photobiomodulation therapy uses red light (660 nm) and near-infrared light (850 nm) to deliver therapeutic energy to the body, calculated by power density multiplied by time. While the same surface dose formula applies to both wavelengths, 850 nm sessions typically need to be extended by 10–20% to ensure adequate energy penetrates to deeper tissues.
Key factors that influence your ideal treatment protocol include:
Because dosing varies so significantly based on individual factors and underlying symptoms, the smartest next step is to clarify what you're actually trying to treat. Whether you're dealing with pain, fatigue, skin concerns, or inflammation, understanding the root cause helps you select the right wavelength, dose, and duration. Take a free, instant, online symptom check to better understand what's going on in your body and confidently navigate your next steps.
Reviewed for medical accuracy: 06/23/2026
Photobiomodulation (PBM), sometimes called red-light or near-infrared therapy, uses specific wavelengths of light to stimulate cellular function, encourage healing, and reduce inflammation. Two of the most commonly studied wavelengths are 660 nm (red) and 850 nm (near-infrared). One question that often comes up is: "660 nm vs 850 nm time difference—should my 850 nm sessions last longer?" Understanding the science behind absorption, penetration, and dose will help you tailor your PBM sessions for the best results.
Absorption Profiles
Penetration Depth
Scattering
To deliver a target energy density (e.g., 5 J/cm²):
Example:
The same math applies at 850 nm—if the device's power density is identical. But remember: deeper penetration doesn't change the surface dose calculation. It changes how much light actually reaches your target tissue.
When comparing session lengths between these wavelengths, consider:
Surface vs. Deep Dose
Device Specifications
Practical Rule of Thumb
| Target Area | Wavelength | Power Density | Dose (J/cm²) | Time per Spot |
|---|---|---|---|---|
| Superficial Skin | 660 nm | 0.05 W/cm² | 6 J/cm² | 120 seconds |
| Muscle / Joint Deep | 850 nm | 0.05 W/cm² | 8 J/cm² | 160 seconds |
| Combined Therapy | 660 + 850 | 0.05 W/cm² | 6–8 J/cm² | 120–160 seconds |
While PBM is generally safe, always err on the side of caution:
Before beginning any new therapy regimen, it's important to understand your current health status and any symptoms you may be experiencing. You can check your symptoms with Ubie's free AI-powered assessment tool to get personalized insights and determine if PBM or other treatments might be appropriate for your situation.
Remember, photobiomodulation is a powerful tool—but it's not a substitute for professional medical care. For any serious or life-threatening issues, always speak to a doctor. And if you're uncertain about whether your symptoms require medical attention, Ubie's AI symptom checker can help you understand what you're experiencing and guide you toward the right next steps for your health.
(References)
* Chung H, Dai T, Sharma SK, Huang YY, Carroll F, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012 Feb;40(2):516-33. doi: 10.1007/s10439-011-0454-7. Epub 2011 Nov 16. PMID: 22095203; PMCID: PMC3288797.
* Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-361. doi: 10.3934/biophy.2017.3.337. eCollection 2017. PMID: 28695277; PMCID: PMC5506019.
* Zein R, El Hajj N, Pereira-Filho OA, Ploton C, Streel B, Van der Smissen P, Nyssen-Behets C, Feron O, Doumont G, Lison D, Cambier S. Effect of photobiomodulation on cell viability, proliferation, and differentiation: a systematic review. Lasers Med Sci. 2023 Dec 16;39(1):79. doi: 10.1007/s10103-023-03930-x. PMID: 38097761; PMCID: PMC10724816.
* Pires D, Sousa AC, Chaves L, Bule P, Gomes J, Rocha R. Photobiomodulation in chronic pain: a systematic review. Lasers Med Sci. 2022 Feb;37(1):1-16. doi: 10.1007/s10103-021-03310-4. Epub 2021 May 19. PMID: 34010469.
* Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose Response. 2009 Mar 1;7(4):358-83. doi: 10.2203/dose-response.09-027.Huang. PMID: 20009403; PMCID: PMC2805166.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.